Dec 24 (Reuters) - China's WuXi AppTec said
on Tuesday its subsidiaries have signed a deal with U.S.-based
private equity firm Altaris LLC for the sale of its cell and
gene therapy manufacturing unit, WuXi Advanced Therapies, for an
undisclosed sum.